Close Menu

NEW YORK (360Dx) – Qiagen said on Monday after the close of the market that it has received regulatory approval from Health Canada for its QuantiFeron-TB Gold Plus (QFT-Plus) in vitro diagnostic test for latent tuberculosis infection.

QFT-Plus features antigens that measure the cell-mediated immune response to TB infection from both CD4 and CD8 T cells, providing a broader assessment of TB infection.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.